Dow Jones

44,736.57

0.99%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

PHAR

Pharming Group NV (PHAR)

Pharming Group NV

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHAR

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
30/05/2024	16:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHAR	Pharming Group NV
24/08/2023	01:00	PR Newswire (US)	Pharming Group to participate in September investor conferences	NASDAQ:PHAR	Pharming Group NV
14/08/2023	00:00	PR Newswire (US)	Pharming Group to convene Extraordinary General Meeting of Shareholders	NASDAQ:PHAR	Pharming Group NV
09/08/2023	00:00	PR Newswire (US)	Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan	NASDAQ:PHAR	Pharming Group NV
03/08/2023	00:00	PR Newswire (US)	Pharming Group reports second quarter and first half 2023 financial results	NASDAQ:PHAR	Pharming Group NV
18/07/2023	00:00	PR Newswire (US)	Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board	NASDAQ:PHAR	Pharming Group NV
13/07/2023	01:00	PR Newswire (US)	Pharming Group to report second quarter and first half 2023 financial results on August 3	NASDAQ:PHAR	Pharming Group NV
01/06/2023	05:15	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:PHAR	Pharming Group NV
01/06/2023	00:00	PR Newswire (US)	Pharming announces sale of priority review voucher	NASDAQ:PHAR	Pharming Group NV
25/05/2023	01:00	PR Newswire (US)	Pharming Group to attend the following Investor Conferences in June	NASDAQ:PHAR	Pharming Group NV
17/05/2023	10:28	PR Newswire (US)	Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders	NASDAQ:PHAR	Pharming Group NV
11/05/2023	00:00	PR Newswire (US)	Pharming Group reports financial results for the first quarter of 2023	NASDAQ:PHAR	Pharming Group NV
26/04/2023	01:00	PR Newswire (US)	Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023	NASDAQ:PHAR	Pharming Group NV
19/04/2023	01:00	PR Newswire (US)	Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023	NASDAQ:PHAR	Pharming Group NV
19/04/2023	00:36	PR Newswire (US)	Notice of First Quarter 2023 Results	NASDAQ:PHAR	Pharming Group NV
13/04/2023	06:11	PR Newswire (US)	Pharming to present at the 22nd Annual Needham Virtual Healthcare Conference 2023	NASDAQ:PHAR	Pharming Group NV
11/04/2023	00:00	PR Newswire (US)	Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.	NASDAQ:PHAR	Pharming Group NV
05/04/2023	05:57	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:PHAR	Pharming Group NV
05/04/2023	01:00	PR Newswire (US)	Pharming Group convenes the Annual General Meeting of Shareholders 2023	NASDAQ:PHAR	Pharming Group NV
05/04/2023	00:00	PR Newswire (US)	Pharming Group announces the filing of its 2022 Annual Report and Form 20-F	NASDAQ:PHAR	Pharming Group NV
30/03/2023	09:39	PR Newswire (US)	Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days	NASDAQ:PHAR	Pharming Group NV
24/03/2023	18:22	Dow Jones News	ADRs End Mostly Lower, Pharming Group Trades Actively	NASDAQ:PHAR	Pharming Group NV
24/03/2023	13:35	PR Newswire (US)	Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS	NASDAQ:PHAR	Pharming Group NV
13/03/2023	04:43	PR Newswire (US)	Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank Limited in light of UK Government announcement	NASDAQ:PHAR	Pharming Group NV
13/03/2023	03:34	Dow Jones News	Pharming Expects to Have Access to $26 Million It Has on Deposit at SVB US	NASDAQ:PHAR	Pharming Group NV
13/03/2023	02:15	PR Newswire (US)	Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement	NASDAQ:PHAR	Pharming Group NV
12/03/2023	13:30	PR Newswire (US)	Pharming Group issues statement regarding the events surrounding Silicon Valley Bank	NASDAQ:PHAR	Pharming Group NV
28/02/2023	00:00	PR Newswire (US)	Notice of Full Year 2022 financial results	NASDAQ:PHAR	Pharming Group NV
21/02/2023	00:00	PR Newswire (US)	Pharming announces first patient enrolled in pediatric clinical trial of leniolisib	NASDAQ:PHAR	Pharming Group NV
16/02/2023	00:00	PR Newswire (Canada)	Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe	NASDAQ:PHAR	Pharming Group NV